Back to Articles
49732026 Full YearPrimeJGAAP

JAPAN PURE CHEMICAL CO.,LTD. FY2026 FY Earnings Report

JAPAN PURE CHEMICAL CO.,LTD. FY2026 FY earnings report and financial analysis

Raw Materials & Chemicals/Chemicals


Quick View

MetricThis PeriodPrior Year Same PeriodYoY
Revenue¥180.7B¥126.1B+43.3%
Operating Income¥5.8B¥5.0B+14.7%
Ordinary Income¥7.8B¥6.6B+18.0%
Net Income¥18.0B¥15.8B+14.2%
ROE10.0%11.6%-

Executive Summary

FY2026 Q2 results: Revenue ¥180.7B (YoY +¥54.6B +43.3%), Operating Income ¥5.8B (YoY +¥0.7B +14.7%), Ordinary Income ¥7.8B (YoY +¥1.2B +18.0%), Net Income ¥18.0B (YoY +¥2.2B +14.2%). Revenue expanded sharply driven by volume increases, but gross margin fell to 10.7% (down 2.2pt from 12.9% a year earlier), reducing profitability; SG&A increases kept Operating Margin at 3.2% (down 0.8pt from 4.0%). Extraordinary gains ¥16.6B (primarily gain on sale of investment securities) supported Net Income, but Operating Cash Flow was ¥-7.7B (significantly worse than prior year ¥+5.8B), showing a steep decline in cash-generating capability. The company retains very strong liquidity with investment securities ¥107.4B and cash ¥77.5B, but the combination of negative Operating Cash Flow and a Payout Ratio of 67.3% warrants attention from a dividend sustainability perspective.

Drivers of Performance

[Revenue] Revenue expanded sharply to ¥180.7B (YoY +43.3%). Although segment disclosure is not provided, the ¥54.6B YoY increase is presumed to stem from higher shipments of existing products and acquisition of new demand. Non-operating income ¥2.2B (mainly dividend income ¥2.0B) is stable but limited at 1.2% of revenue. Extraordinary gains ¥16.6B (gain on sale of investment securities ¥16.6B) lifted Profit Before Tax to ¥24.3B.

[Profitability] Gross profit was ¥19.4B with a gross margin of 10.7% (down 2.2pt from 12.9%). Increases in raw material and manufacturing costs and delays in passing on price increases appear to have pressured margins. SG&A was ¥13.6B (up 20.4% from ¥11.3B a year earlier), growing well below revenue growth, so operating leverage did not materialize. As a result, Operating Income remained ¥5.8B (+14.7%), with an Operating Margin of 3.2% (down 0.8pt from 4.0%). Ordinary Income ¥7.8B (+18.0%) exceeded Operating Income due to stable non-operating income, but Net Income ¥18.0B (+14.2%) was heavily dependent on the extraordinary gain of ¥16.6B, highlighting weakness in recurring earnings. After income taxes of ¥6.3B, Net Margin was 10.0% (down 2.5pt from 12.5%). Overall, revenue growth was offset by rising costs.

Key Financial Metrics

[Profitability] Operating Margin 3.2% (prior year 4.0%), Net Margin 10.0% (prior year 12.5%). The decline in Gross Margin to 10.7% (prior year 12.9%) is the primary driver of compressed Operating Margin. ROE 10.0% (prior year 11.3%) remains at a healthy level, but calculated as Net Margin 10.0% × Total Asset Turnover 0.83 × Financial Leverage 1.20x, the fall in Net Margin reduced contribution. [Cash Quality] Operating Cash Flow -¥7.7B, Operating CF/Net Income -0.43x indicates deterioration in cash quality. Increases in Accounts Receivable +¥7.4B and Inventory +¥0.9B and corporate tax payments -¥8.0B were primary drivers. OCF/EBITDA -1.16x shows weak cash conversion. [Investment Efficiency] Total Asset Turnover 0.83x (prior year 0.80x) improved. Investment securities ¥107.4B account for 49.4% of total assets, making the asset base sensitive to market conditions. Capital expenditures ¥0.7B and depreciation ¥0.9B yield CapEx/Depreciation 0.79x, indicating restrained investment. [Financial Soundness] Equity Ratio 83.1% (prior year 85.2%), Current Ratio 1567%—extremely healthy. Debt-to-equity 0.20x and cash ¥77.5B far exceed short-term debt ¥6.8B, minimizing maturity mismatch risk. Deferred tax liabilities ¥27.7B arise from valuation differences on investment securities, posing equity erosion risk if market values decline.

Cash Flow Analysis

Operating Cash Flow was -¥7.7B (worsening ¥13.5B from prior year +¥5.8B), representing -0.43x of Net Income ¥18.0B and raising quality concerns. Operating cash flow before working capital changes was -¥1.5B, and working capital changes produced a net cash outflow of -¥6.9B driven by Accounts Receivable increase -¥7.4B (extended collection terms amid rapid sales growth), Inventory increase -¥0.9B (stock build for demand) and Accounts Payable increase +¥0.5B (slight extension of payment terms). Corporate tax payments -¥8.0B further weighed on cash, leaving OCF/EBITDA at -1.16x and highlighting weak conversion. Investing Cash Flow was +¥11.1B, led by proceeds from sale of investment securities ¥17.4B, net of CapEx -¥0.7B and purchase of securities -¥0.1B. Free Cash Flow was ¥3.4B but insufficient to cover dividend payments ¥7.3B (full-year assumption), resulting in Financing Cash Flow -¥6.7B (dividends -¥7.3B, treasury stock purchase -¥0.0B, disposal of treasury stock +¥0.6B). Cash decreased ¥3.3B year-over-year to ¥77.5B but liquidity remains ample. Going forward, accelerating receivables collection, normalizing inventory turnover, and smoothing tax effects to restore Operating Cash Flow are key to dividend sustainability.

Earnings Quality

Ordinary Income ¥7.8B versus Net Income ¥18.0B shows a 2.3x gap, revealing heavy reliance on extraordinary gains ¥16.6B (gain on sale of investment securities). Non-operating income ¥2.2B (dividend income ¥2.0B, foreign exchange gains, etc.) is stable but limited at 1.2% of revenue. Non-operating expenses ¥0.2B (fees) are minor. From an accrual perspective, the divergence between Operating Cash Flow -¥7.7B and Net Income ¥18.0B (-¥25.7B) is significant, mainly due to working capital increases Accounts Receivable +¥7.4B, Inventory +¥0.9B and corporate tax payments -¥8.0B. The extraordinary gain ¥16.6B is one-off; recurring earning power is concentrated in Operating Income ¥5.8B (Operating Margin 3.2%). The buildup of Deferred Tax Liabilities ¥27.7B stems from unrealized gains on investment securities and poses valuation difference risk in market downturns.

Forecasts & Guidance

Full-year plan (Revenue ¥240.0B, Operating Income ¥6.1B, Ordinary Income ¥8.0B, Net Income ¥21.7B): as of Q2, progress rates are Revenue 75%, Operating Income 95%, Ordinary Income 98%, Net Income 83%—ahead of schedule. Operating and Ordinary Income are nearly meeting full-year plans, and with the contribution of Extraordinary Gains ¥16.6B Net Income has reached 83% of plan. However, Gross Margin 10.7% and Operating Margin 3.2%—while slightly better than plan (Operating Margin assumed around 2.5%)—the negative Operating Cash Flow -¥7.7B and weak cash generation suggest risk to delivering the plan. Full-year EPS forecast ¥373.93 versus Q2 realized EPS ¥311.86 (83% progress) is on track, but improvements in second-half profitability and normalization of cash flows are prerequisites for meeting full-year targets.

Shareholder Returns

Interim dividend was ¥63, year-end planned ¥137, total ¥200 per share—significantly exceeding the full-year plan of ¥115 per share. Payout Ratio is 67.3% (Dividend ¥200 ÷ EPS ¥297.0) which is relatively high. Free Cash Flow ¥3.4B versus dividend payments ¥7.3B (full-year assumption) yields FCF coverage 0.47x, meaning dividends cannot be covered by internal funds alone. However, cash ¥77.5B and strong liquidity mean there is no short-term issue in paying dividends. Treasury stock purchases were -¥0.0B (effectively zero), so Total Return Ratio equals the Payout Ratio. Given the risk of continued negative Operating Cash Flow, medium-term dividend sustainability depends on recovery of core earnings and OCF, and on reducing reliance on gains from sale of investment securities.

Risk Factors

  1. Low gross margin structure risk: Gross Margin 10.7% (down 2.2pt from 12.9%) makes earnings highly sensitive to increases in raw material and manufacturing costs. SG&A ¥13.6B (7.5% of revenue) consumes 70% of gross profit, limiting operating leverage. Delays in price pass-through or product-mix improvement could further depress Operating Margin from the current 3.2%.

  2. Operating CF deterioration risk: Operating CF -¥7.7B (OCF/Net Income -0.43x) with working capital expansion Accounts Receivable +¥7.4B and Inventory +¥0.9B continuing. If extended collection terms and inventory buildup become persistent with rapid sales growth, cash generation could deteriorate structurally. FCF ¥3.4B cannot cover dividends ¥7.3B, making OCF recovery essential for sustained returns.

  3. Investment securities dependence risk: Investment securities ¥107.4B (49.4% of total assets) with Deferred Tax Liabilities ¥27.7B accumulated. Market downturns could shrink valuation differences, erode equity, and reduce Deferred Tax Liabilities, shrinking the balance sheet. Dependence on Extraordinary Gains ¥16.6B is temporary and exposes the weakness of recurring earnings.

Industry Benchmark (Reference, Company Estimates)

Profitability & Return

MetricCompanyMedian (IQR)Delta
Operating Margin3.2%7.8% (4.6%–12.3%)−4.6pt
Net Margin10.0%5.2% (2.3%–8.2%)+4.8pt

Operating Margin is 4.6pt below the industry median (placing the company in the lower ranks), while Net Margin is 4.8pt above the median due to contribution from extraordinary gains.

Growth & Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (YoY)43.3%3.7% (-0.4%–9.3%)+39.6pt

Revenue growth markedly outpaces the industry median by 39.6pt, placing the company among the leaders in growth pace.

※ Source: Company compilation

Key Points from the Results

  1. The biggest highlight is the weak profitability: Operating Margin 3.2% versus industry median 7.8% (down 4.6pt). Low Gross Margin 10.7% and heavy SG&A at 7.5% of sales (70% of gross profit) impede operating leverage. Recovery of core margins via price adjustments, product-mix improvement, and manufacturing efficiency is essential; observing a trend reversal in Gross Margin and Operating Margin over coming quarters will be critical.

  2. Operating CF -¥7.7B (OCF/Net Income -0.43x) shows a steep decline in cash generation; FCF ¥3.4B cannot cover dividends ¥7.3B. Working capital expansion Accounts Receivable +¥7.4B and Inventory +¥0.9B are main drivers, so faster receivables collection and improved inventory turnover to normalize OCF are prerequisites for dividend sustainability. Cash ¥77.5B provides short-term buffer, but medium-term requires simultaneous improvement in core earnings and cash flow.

  3. Most of Net Income ¥18.0B is attributable to Extraordinary Gains ¥16.6B (gain on sale of investment securities); recurring earnings are concentrated in Operating Income ¥5.8B (Operating Margin 3.2%). The mix of Investment Securities ¥107.4B (49.4% of assets) and Deferred Tax Liabilities ¥27.7B embeds balance sheet volatility risk with market fluctuations. Eliminating reliance on one-off gains and shifting to stable growth on an operating-income basis are structural issues highlighted by the results.


This report was generated by AI analyzing XBRL financial statement data to produce an automated earnings analysis. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company based on public financial statements. Investment decisions should be made at your own responsibility; consult a professional advisor as needed.